GNH USA

Europe — EMA

Lenalidomid Grindeks

GNH USA supplies Lenalidomid Grindeks (Lenalidomide), a immunomodulatory imide drug for multiple myeloma and del(5q) myelodysplastic syndromes.

Lenalidomide

Request sourcing

1
Pack/s

What is Lenalidomide?

Lenalidomide, the active ingredient in Lenalidomid Grindeks, is a immunomodulatory imide drug (IMiD) presented as a tablet for oral use. It treats multiple myeloma and myelodysplastic syndromes with del(5q) in adult patients.

GNH USA supplies Lenalidomid Grindeks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

What is Lenalidomide used for?

Lenalidomid Grindeks is an immunomodulatory agent used in specific hematologic malignancies.

Multiple Myeloma: improves disease control and prolongs progression‑free survival. Myelodysplastic Syndromes with del(5q): reduces transfusion dependence and improves hematologic parameters.

What are the side effects of Lenalidomide?

Lenalidomid Grindeks may cause a range of adverse reactions.

Common Side Effects: - Fatigue: persistent tiredness reported by many patients. - Neutropenia: reduced neutrophil count increasing infection risk. - Thrombocytopenia: lowered platelet levels leading to bruising. - Anemia: decreased red blood cell count causing weakness. - Diarrhea: loose stools of varying severity. - Rash: mild skin irritation or erythema.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Severe neutropenia: profound immune suppression requiring medical attention. - Secondary primary malignancies: emergence of new cancers. - Hepatic failure: significant liver enzyme elevations or dysfunction. - Stevens‑Johnson syndrome: severe skin reaction with blistering.

What precautions apply to Lenalidomide?

Before initiating therapy, clinicians should evaluate several safety considerations.

Monitor blood counts: perform regular CBC to detect cytopenias. Assess thrombotic risk: consider prophylactic anticoagulation when risk is high. Evaluate organ function: check renal and hepatic parameters periodically. Avoid in pregnancy: teratogenic potential requires strict contraception. Use contraception: both male and female patients must employ effective methods. Store below 25°C: keep in the original pack, protect from moisture.

What does Lenalidomide interact with?

Lenalidomid Grindeks can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase lenalidomide exposure. - Thalidomide: combined use heightens teratogenic risk. - Anticoagulants: concurrent use can raise clotting complications.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers: may reduce therapeutic levels. - NSAIDs: increase risk of gastrointestinal bleeding.

Frequently asked questions

What conditions is Lenalidomid Grindeks used for?+
Lenalidomid Grindeks is prescribed for adult patients with multiple myeloma and for myelodysplastic syndromes that carry the del(5q) chromosomal abnormality. In these settings it helps control disease progression and can reduce the need for blood transfusions.
How does lenalidomide work in the body?+
Lenalidomide binds to cereblon, a component of the CRL4‑CRBN E3 ubiquitin ligase complex. This binding changes the complex’s target proteins, leading to the degradation of transcription factors that promote tumor growth, while also exerting anti‑angiogenic and immune‑enhancing effects.
What is the usual dose of Lenalidomid Grindeks?+
The dose of Lenalidomid Grindeks is individualized by the prescribing clinician based on the specific indication, patient characteristics, and treatment goals. Only a qualified healthcare professional should determine the appropriate regimen.
Is Lenalidomid Grindeks safe during pregnancy or breastfeeding?+
Lenalidomid Grindeks is classified as teratogenic and should not be used during pregnancy. Women of child‑bearing potential must use effective contraception. Safety during breastfeeding has not been established, so the drug is generally avoided while nursing.
How do I order Lenalidomid Grindeks from GNH USA?+
To request Lenalidomid Grindeks, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Lenalidomid Grindeks compare with other treatments for multiple myeloma?+
Lenalidomid Grindeks belongs to the immunomodulatory imide drug class, offering a distinct mechanism from proteasome inhibitors or monoclonal antibodies. It is often used in combination regimens and provides benefits such as oral administration and a different side‑effect profile, making it a valuable option in multi‑drug treatment strategies.
What are the recommended storage conditions for Lenalidomid Grindeks?+
Store Lenalidomid Grindeks tablets at temperatures below 25 °C in their original packaging. Protect the tablets from moisture and direct sunlight to maintain stability and potency throughout the shelf life.
How is Lenalidomid Grindeks administered?+
Lenalidomid Grindeks is taken orally as a tablet, usually with or without food as directed by the prescriber. Patients should follow the dosing schedule provided by their healthcare professional and not alter the regimen without medical advice.
What are the most serious risks associated with Lenalidomid Grindeks?+
The most serious risks include severe neutropenia, venous thromboembolism, secondary primary malignancies, and rare but severe skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored closely for signs of infection, clotting events, or unusual skin changes.
Who should not use Lenalidomid Grindeks?+
Lenalidomid Grindeks should not be used by individuals who are pregnant, have uncontrolled infections, or have a known hypersensitivity to lenalidomide or any component of the tablet. It is also contraindicated in patients with severe renal or hepatic impairment unless specifically approved by a specialist.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Lenalidomide
Route
Oral Use
Manufacturer
Grindeks
Origin
EU

Related products